4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001692444-26-000008
Director sold 599 shares at $85.47 ($51,197)
- Director acquired 599 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Soteropoulos Paula Director | 2026-05-08 | Option exercise 10b5-1 | +599 | $8.44 | $5,056 | 599 | D |
| Soteropoulos Paula Director | 2026-05-08 | Sale 10b5-1 | −599 | $85.47 | $51,197 | 0 | D |
| Derivatives | |||||||
| Soteropoulos Paula Director | 2026-05-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −599 | 0 | D | ||
| Open-market sales · 599 sh · avg $85.47 · $51,197 | |||||||
Loading xslF345X06/ownership.xml…